HANA EL SAHLY to Vaccines
This is a "connection" page, showing publications HANA EL SAHLY has written about Vaccines.
Connection Strength
1.756
-
Messenger ribonucleic acid vaccines for severe acute respiratory syndrome coronavirus-2 - a review. Transl Res. 2022 04; 242:1-19.
Score: 0.514
-
The Reply. Am J Med. 2019 08; 132(8):e668.
Score: 0.430
-
Vaccination in the Adult Patient Infected with HIV: A Review of Vaccine Efficacy and Immunogenicity. Am J Med. 2019 04; 132(4):437-446.
Score: 0.418
-
Stochastic interventional approach to assessing immune correlates of protection: Application to the COVE messenger RNA-1273 vaccine trial. Int J Infect Dis. 2023 Dec; 137:28-39.
Score: 0.146
-
Rapid Development of an Integrated Network Infrastructure to Conduct Phase 3 COVID-19 Vaccine Trials. JAMA Netw Open. 2023 01 03; 6(1):e2251974.
Score: 0.138
-
A phase 1 study of the safety, reactogenicity, and immunogenicity of a Schistosoma mansoni vaccine with or without glucopyranosyl lipid A aqueous formulation (GLA-AF) in healthy adults from a non-endemic area. Vaccine. 2019 10 08; 37(43):6500-6509.
Score: 0.110